Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mucosta trial in Sjogren syndrome-related dry eye
jRCT1031220298Completed
- Sponsor
- Clinical Research Initiation-Fund (of Chiba University Hospital)
- Start
- Nov 2022
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial in dry eye syndrome (DED) and Sjögren's syndrome comparing Mucosta group with Hyalein group (2 arms). Primary endpoint: Primary efficacy endpoint. Started Nov 2022; status: completed.
02
Drugs
rebamipidesodium hyaluronate
03
Conditions
dry eye syndrome (DED)Sjögren's syndrome
Beyond the preview
Go deeper on jRCT1031220298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1031220298.